Abstract |
We compared the protective effect of DS-4574, a peptidoleukotriene receptor antagonist with mast cell stabilizing action, on rat gastric mucosal injury induced by acidified ethanol to that of LY171883, a selective peptidoleukotriene receptor antagonist. Oral treatment with DS-4574 (1-10 mg/kg) or LY171883 (100 and 300 mg/kg) markedly suppressed this mucosal necrosis. Moreover, DS-4574 (10 mg/kg) significantly inhibited both mucosal edema and degranulation of mucosal mast cells. LY171883 (300 mg/kg) protected only from mucosal edema, but not degranulation of mucosal mast cells. These results suggest that DS-4574 possesses protective actions against gastric injury including the reduction of degranulation of mucosal mast cells, which are different from those of LY171883.
|
Authors | Y Tabuchi, K Kawarabayashi, T Komada, K Furuhama |
Journal | European journal of pharmacology
(Eur J Pharmacol)
Vol. 250
Issue 1
Pg. 197-9
(Nov 30 1993)
ISSN: 0014-2999 [Print] Netherlands |
PMID | 7907021
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Acetophenones
- Autacoids
- Leukotriene Antagonists
- Pyrimidines
- Tetrazoles
- Triazoles
- DS 4574
- Ethanol
- LY 171883
|
Topics |
- Acetophenones
(pharmacology, therapeutic use)
- Animals
- Autacoids
(antagonists & inhibitors)
- Cell Degranulation
(drug effects)
- Edema
(drug therapy)
- Ethanol
(toxicity)
- Gastric Mucosa
(drug effects, pathology)
- Hydrogen-Ion Concentration
- Leukotriene Antagonists
- Male
- Mast Cells
(drug effects)
- Necrosis
(drug therapy)
- Pyrimidines
(pharmacology, therapeutic use)
- Rats
- Rats, Sprague-Dawley
- Tetrazoles
(pharmacology, therapeutic use)
- Triazoles
(pharmacology, therapeutic use)
|